Table 2 Characteristics of validation cohort
Morbidity(n = 12) | Control(n = 21) | *p value | |
|---|---|---|---|
Gender male n% | 10(83%) | 14(67.7%) | 0.0096 |
pH | 7.16(0.19) | 7.156(0.19) | 0.87855251 |
Scr (mg/dL) | 1.3276(0.2802) | 1.4266(0.5148) | 0.47718778 |
BUN (mg/dL) | 12.50(5.27) | 13.39(6.29) | 0.66546308 |
K+ (mEq/L) | 5.54(1.30) | 5.53(1.36) | 0.97629452 |
Na+ (mEq/L) | 137.23(7.63) | 139.25(7.29) | 0.46464174 |
WBC (K/uL) | 14.45(4.89) | 15.29(6.52) | 0.67758494 |
Hb (g/dL) | 10.59(1.98) | 9.74(1.99) | 0.24255486 |
PLT (K/uL) | 109.81(37.45) | 103.02(39.89) | 0.62799096 |
Lactate (mmol/L) | 3.54(1.43) | 2.28(2.02) | 0.04430989 |
CRP (mg/dL) | 67.27(17.12) | 68.3(14.82) | 0.86302044 |
IL6 (pg/mL) | 785.49(154.24) | 728.52(146.97) | 0.30742201 |
TNF (ng/L) | 53.31(13.28) | 48.90(12.05) | 0.35103748 |
CD4 (#/uL) | 369.0(85.7) | 367.5(95.0) | 0.96201768 |
CD8 (#/uL) | 403.8(105.4) | 39.58(9.75) | 0.83142445 |
SOFA | 6.38(1.24) | 6.66(0.98) | 0.50066978 |